Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $367,468 - $497,803
-3,101 Reduced 10.11%
27,575 $3.35 Million
Q1 2023

May 03, 2023

BUY
$135.66 - $197.02 $48,159 - $69,942
355 Added 1.17%
30,676 $4.71 Million
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $106,542 - $189,036
900 Added 3.06%
30,321 $5.45 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $309,933 - $509,722
-2,625 Reduced 8.19%
29,421 $3.48 Million
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $325,152 - $490,213
-2,776 Reduced 7.97%
32,046 $4.58 Million
Q1 2022

May 11, 2022

BUY
$126.46 - $235.05 $927,078 - $1.72 Million
7,331 Added 26.67%
34,822 $6 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $307,115 - $501,173
1,360 Added 5.2%
27,491 $4.41 Million
Q3 2021

Nov 16, 2021

SELL
$221.9 - $484.47 $4.9 Million - $10.7 Million
-22,073 Reduced 45.79%
26,131 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $116,009 - $209,837
893 Added 1.89%
48,204 $11.3 Million
Q1 2021

Jun 16, 2021

BUY
$109.18 - $185.98 $478,645 - $815,336
4,384 Added 10.21%
47,311 $6.2 Million
Q4 2020

Jan 25, 2021

BUY
$65.74 - $169.86 $2.82 Million - $7.29 Million
42,927 New
42,927 $4.94 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Nia Impact Advisors, LLC Portfolio

Follow Nia Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nia Impact Advisors, LLC with notifications on news.